Keya Hatkar, a young author and motivational speaker with Spinal Muscular Atrophy, inspires others with her resilience and ...
Haris Beeran urges government intervention to make affordable SMA medicines available in India, addressing the high costs and patent issues.
Upper House member Haris Beeran has said the current costs of medicines approved for SMA are 'beyond the reach of the central ...
Novartis has recently announced that its intrathecal (IT) formulation of onasemnogene abeparvovec (OAV101 IT) successfully ...
Novartis has recently announced that its intrathecal (IT) formulation of onasemnogene abeparvovec (OAV101 IT) successfully achieved the primary endpoint in a Phase III STEER study (NCT05089656) ...
Centre informed Supreme Court that providing free gene therapy for Spinal Muscular Atrophy (SMA) could cost India Rs ...
On 30 December 2024, Novartis reported that its intrathecal (IT) formulation of onasemnogene abeparvovec (OAV101 IT) reached ...
He spent time at Nationwide Children’s Hospital. In November of 2023, Jackson was told he was going home. He thought this ...
NMD Pharma Announces FDA Orphan Drug Designation Granted to NMD670 for the Treatment of Patients with Charcot-Marie-Tooth Disease This is the 2nd ...
Prior to Saturday’s women’s basketball game between West Virginia and BYU, the WVU women’s basketball team invited a young ...
The US Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to NMD Pharma’s oral lead development ...
More than three years after Novartis’ plan for a speedy approval for intrathecal Zolgensma was thwarted by an FDA requirement ...